Cross-Sector entity
Cellebrite is most often covered alongside Apple, which appears in 1 of these 2 stories. Across a 179-day span, the pace is roughly 0.1 stories per week. court-decisions accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder.
2 verified stories tracked
Last mentioned: Aug 18, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Cellebrite is most often covered alongside Apple, which appears in 1 of these 2 stories. Across a 179-day span, the pace is roughly 0.1 stories per week. court-decisions accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Cellebrite appears in 2 tracked Cross-Sector stories published from February 21, 2026 through August 18, 2026. The tracked stories average 3 original sources each.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Cellebrite. Shared-story counts are live from our verified record — not editorial picks.
Prosecution rests its case
After 13 days of testimony and nearly 70 witnesses, the prosecution rested with final witness Ian Whiffin of Cellebrite testifying about Apple health data.
Judge says trial 'well on track'
Judge William Sullivan told jurors before the weekend that the case was on schedule.
Clancy reports auditory hallucination
Patrick Clancy said Lindsay told him about a man's voice telling her this was her last chance, one week after the killings.
Children killed and Clancy injured
Lindsay Clancy allegedly strangled her three children, Cora, Dawson and Callan, in Duxbury, Massachusetts, then jumped from a second-floor window, leaving her partially paralyzed.
The prosecution has closed its case in the Lindsay Clancy triple-murder trial after 13 days and nearly 70 witnesses, punctuated by Cellebrite testimony on Apple health data. The defense now shifts to a postpartum psychosis lack-of-criminal-responsibility argument.
Source: wxii12.com · wesh.com
TD Cowen has downgraded digital intelligence leader Cellebrite (CLBT), citing a broader contraction in the forensics market. Despite the company's robust annual recurring revenue growth, analysts warn that tightening government budgets and market saturation could limit near-term upside.
Source: finance.yahoo.com · insidermonkey.com
